Visualising structural and functional characteristics distinguishing between newly diagnosed high-tension and low-tension glaucoma patients.
normal-tension glaucoma
open-angle glaucoma
optical coherence tomography
perimetry
primary open-angle glaucoma
visual fields
Journal
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)
ISSN: 1475-1313
Titre abrégé: Ophthalmic Physiol Opt
Pays: England
ID NLM: 8208839
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
03
03
2023
received:
13
12
2022
accepted:
07
03
2023
medline:
7
6
2023
pubmed:
26
3
2023
entrez:
25
3
2023
Statut:
ppublish
Résumé
To determine whether there are quantifiable structural or functional differences that can distinguish between high-tension glaucoma (HTG; intraocular pressure [IOP] > 21 mm Hg) and low-tension glaucoma (LTG; IOP ≤ 21 mm Hg) at diagnosis. This was a retrospective, cross-sectional study. Clinical results of one eye from 90 newly diagnosed HTG and 319 newly diagnosed LTG patients (117 with very-low-tension glaucoma [vLTG; ≤15 mm Hg] and 202 with middling LTG [mLTG; >15 mm Hg, ≤21 mm Hg]) were extracted, which included relevant demographic covariates of glaucoma, quantitative optical coherence tomography (including the optic nerve head, retinal nerve fibre layer and ganglion cell-inner plexiform layer) measurements and standard automated perimetry global metrics. We used binary logistic regression analysis to identify statistically significant clinical parameters distinguishing between phenotypic groups for inclusion in principal component (PC) (factor) analysis (PCA). The separability between each centroid for each cohort was calculated using the Euclidean distance (d(x,y)). The binary logistic regression comparing HTG and all LTG identified eight statistically significant clinical parameters. Subsequent PCA results included three PCs with an eigenvalue >1. PCs 1 and 2 accounted for 21.2% and 20.2% of the model, respectively, with a d(x,y) = 0.468, indicating low separability between HTG and LTG. The analysis comparing vLTG, mLTG and HTG identified 15 significant clinical parameters, which were subsequently grouped into five PCs. PCs 1 and 2 accounted for 24.1% and 17.8%, respectively. The largest separation was observed between vLTG and HTG (d(x,y) = 0.581), followed by vLTG and mLTG (d(x,y) = 0.435) and lastly mLTG and HTG (d(x,y) = 0.210). Conventional quantitative structural or functional parameters could not distinguish between pressure-defined glaucoma phenotypes at the point of diagnosis and are therefore not contributory to separating cohorts. The overlap in findings highlights the heterogeneity of the primary open-angle glaucoma clinical presentations among pressure-defined groups at the cohort level.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
771-787Informations de copyright
© 2023 The Authors. Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists.
Références
Curr Opin Ophthalmol. 2003 Apr;14(2):86-90
pubmed: 12698048
Korean J Ophthalmol. 2014 Dec;28(6):473-8
pubmed: 25435750
Ophthalmol Glaucoma. 2020 Jul - Aug;3(4):274-287
pubmed: 33012332
Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):831-8
pubmed: 22903819
Br J Ophthalmol. 2021 Apr;105(4):496-501
pubmed: 32493759
Emerg Med J. 2003 Jan;20(1):54-60
pubmed: 12533370
Arch Ophthalmol. 2001 Oct;119(10):1492-9
pubmed: 11594950
Clin Exp Optom. 2016 Jul;99(4):373-81
pubmed: 26996257
Am J Ophthalmol. 2021 Jan;221:115-130
pubmed: 32777379
Stat Med. 2014 May 30;33(12):2077-2102
pubmed: 24918242
Ophthalmic Physiol Opt. 2015 Mar;35(2):212-24
pubmed: 25684127
Ophthalmology. 2021 Oct;128(10):1405-1416
pubmed: 33722636
Am J Ophthalmol. 1984 Jun;97(6):730-7
pubmed: 6731537
Zhonghua Yan Ke Za Zhi. 2005 Feb;41(2):136-40
pubmed: 15840340
Int J Ophthalmol. 2018 May 18;11(5):828-834
pubmed: 29862184
Ophthalmic Physiol Opt. 2022 Sep;42(5):973-985
pubmed: 35598152
Clin Exp Ophthalmol. 2018 Sep;46(7):826-828
pubmed: 29498181
Am J Ophthalmol. 2018 Dec;196:10-17
pubmed: 30099037
Graefes Arch Clin Exp Ophthalmol. 2018 Jun;256(6):1179-1186
pubmed: 29450622
Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1345-57
pubmed: 24859387
J R Soc Interface. 2015 Feb 6;12(103):
pubmed: 25505132
Clin Exp Ophthalmol. 2015 May-Jun;43(4):308-19
pubmed: 25362898
Am J Ophthalmol. 1998 Oct;126(4):487-97
pubmed: 9780093
Optom Vis Sci. 2008 Jul;85(7):538-42
pubmed: 18594346
Ophthalmic Physiol Opt. 2023 Jul;43(4):771-787
pubmed: 36964934
Acta Ophthalmol. 2015 Feb;93(1):e22-8
pubmed: 24965201
Jpn J Ophthalmol. 2020 May;64(3):278-284
pubmed: 32062849
Ophthalmology. 2009 Dec;116(12):2271-6
pubmed: 19854514
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Br J Ophthalmol. 1966 Oct;50(10):570-86
pubmed: 5954089
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):788-791
pubmed: 29392325
J Glaucoma. 2007 May;16(3):293-6
pubmed: 17438422
Arch Ophthalmol. 2003 Jan;121(1):48-56
pubmed: 12523884
Transl Vis Sci Technol. 2022 Jan 3;11(1):27
pubmed: 35044445
Arch Ophthalmol. 1982 Jul;100(7):1074-7
pubmed: 7092645
Am J Ophthalmol. 1986 Feb 15;101(2):204-7
pubmed: 3946537
Acta Ophthalmol. 2016 Nov;94(7):692-696
pubmed: 27213294
J Glaucoma. 2004 Aug;13(4):291-8
pubmed: 15226657
Am J Ophthalmol. 2020 Nov;219:317-331
pubmed: 32621896
Ophthalmology. 2009 Apr;116(4):717-24
pubmed: 19243824
Am J Ophthalmol. 1992 Dec 15;114(6):758-63
pubmed: 1463046
J Glaucoma. 2010 Mar;19(3):151-7
pubmed: 19223786
Am J Ophthalmol. 2021 Mar;223:119-128
pubmed: 32777374
Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
pubmed: 12049575
Drug Discov Today. 2017 Jul;22(7):1069-1076
pubmed: 28111329
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3169-76
pubmed: 16123416
BMJ Open Ophthalmol. 2021 Dec 28;6(1):e000921
pubmed: 35028419
Graefes Arch Clin Exp Ophthalmol. 2003 Jul;241(7):541-545
pubmed: 12819980
Clin Exp Optom. 2020 Mar;103(2):212-219
pubmed: 31119793
Surv Ophthalmol. 2007 Nov;52 Suppl 2:S162-73
pubmed: 17998042
Clin Exp Optom. 2021 Sep;104(7):795-804
pubmed: 33689627
Artif Intell Med. 2019 Mar;94:110-116
pubmed: 30871677
Acta Ophthalmol Scand. 1996 Aug;74(4):364-7
pubmed: 8883552
Am J Ophthalmol. 1989 Dec 15;108(6):636-42
pubmed: 2596542
Ophthalmology. 2012 Mar;119(3):443-9
pubmed: 22035576
Ophthalmology. 2011 Sep;118(9):1782-9
pubmed: 21665283
J Glaucoma. 2013 Feb;22(2):133-9
pubmed: 21701394
Lancet. 2004 May 22;363(9422):1711-20
pubmed: 15158634
Optom Vis Sci. 2021 Nov 1;98(11):1321-1331
pubmed: 34538849
Acta Ophthalmol. 2013 Aug;91(5):e386-91
pubmed: 23387808
Korean J Ophthalmol. 2008 Dec;22(4):236-41
pubmed: 19096240
Ophthalmology. 2021 Jan;128(1):P71-P150
pubmed: 34933745
Ophthalmology. 1999 Nov;106(11):2144-53
pubmed: 10571351
J Ophthalmol. 2012;2012:327326
pubmed: 22496961
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2613-20
pubmed: 12766064
Arch Ophthalmol. 2002 Oct;120(10):1268-79
pubmed: 12365904
Multivariate Behav Res. 1966 Apr 1;1(2):245-76
pubmed: 26828106
Ophthalmology. 2021 Apr;128(4):545-553
pubmed: 32898515
Ophthalmology. 2020 Feb;127(2):167-176
pubmed: 31648802